Tumour-associated proteins in oral squamous cell carcinomas by proteomics

Cancer Genomics and Proteomics

Volumn 2, Issue 6, 2005, Pages 353-363

  Ibrahim, Salah Osman ^a   Miron, Talia ^b   Krohn, Marit ^c   Amaratunga, Asoka N ^d   Warnakulasauriya, Saman ^e   Vasstrand, Endre Normann ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF PERADENIYA   (Sri Lanka)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody microarrays; Ionization time of flight mass spectrometry; Mass spectrometry; Matrix assisted laser desorption; Protein profiling

Indexed keywords

CALGRANULIN; GLUTATHIONE TRANSFERASE; PROTEIN NEK2; PROTEIN P56DOK2; PSORIASIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUTH CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; SQUAMOUS CELL CARCINOMA; SRI LANKA; SUDAN; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 30044434694     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Moore SR, Johnson NW, Pierce AM and Wilson DF: Review: The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6: 65-74, 2000.
2. Moore SR, Johnson NW, Pierce AM and Wilson DF: Review: oral oncology: the epidemiology of tongue cancer: a review of global incidence. Oral Dis 6: 75-84, 2000.
3. Franceschi S, Bidoli E, Herrero R and Munoz N: Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Eur J Cancer (Oral Oncol) 36B: 106-115, 2000.
4. Ferlay J, Parkin DM, Pissani P and Globacan I: Cancer incidence and mortality worldwide. IARC Press CD Rom, Lyon, IARC, 2004.
5. Idris AM, Ahmed HM and Malik MOA: Toombak dipping and cancer of the oral cavity in the Sudan: case-control study. Int J Cancer 63: 477-480, 1995.
6. Idris AM, Ibrahim SO, Vasstrand EN et al: The Swedish snus and the Sudanese toombak: are they different? Oral Oncol 34: 558-566, 1998.
7. Idris AM, Nair J, Ohshima H et al: Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis 12: 1115-1118, 1991.
8. IARC (2004): Tobacco habits other than smoking; bete1-quid and areca nut chewing; and related nitrosamines. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC Scientific Publications, Lyon 37: 141-202, 2004.
9. Hoffmann D, Brunnemann KD, Prokopczyk B and Djordjevic MV: Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health 41: 1-52, 1994.
10. Schramm A, Apostolov O, Sitek B, Pfeiffer K et al: Proteomics: techniques and applications in cancer research. Klin Padiatr 275: 293-297, 2003.
11. Marvin LF, Roberts MA and Fay LB: Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry. Clin Chim Acta 337: 11-21, 2003.
12. Glokler J and Angenendt P: Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 797: 229-240, 2003.
13. Schliephake H: Prognostic relevance of molecular markers of oral cancer-a review. Int J Oral Maxillofac Surg 32: 233-245, 2003.
14. He Q-Y, Chen J, Kung H-F, Yuen A P-W and Chiu J-F: Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4: 271-278, 2004.
15. Ghafouri B, Tagesson C and Lindahl M: Mapping of proteins in human saliva using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 3: 1003-1015, 2003.
16. Wu W, Tang X, Hu W, Lotan R et al: Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19: 319-326, 2002.
17. Rodrigo MC, Martin DS, Redetzke RA and Eyster KM: A method for the extraction of high-quality RNA and protein from single small samples of arteries and veins preserved in RNAlater. J Pharmacol Toxicol Methods 47: 87-92, 2002.
18. Cawson RA and Eveson J: Oral Pathology and Diagnosis 13: pp. 10-13, Gower, London, 1987.
19. Rabilloud T, Adessi C, Giraudel A and Lunardi J: Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 18: 307-316, 1997.
20. Berven FS, Karlsen OA, Murrell JC and Jensen HB: Multiple polypeptide forms observed in two-dimensional gels of Methylococcus capsulatus (Bath) polypeptides are generated during the separation procedure. Electrophoresis 24: 757-761, 2003.
21. Karlsen OA, Ramsevik L, Bruseth LJ et al: Characterization of a prokaryotic haemerythrin from the methanotrophic bacterium Methylococcus capsulatus (Bath). FEBS J 272: 2428-2440, 2005.
22. Polo SE, Theocharis SE, Klijanienko J, Savignoni A et al: Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells. Cancer Res 64: 2371-2381, 2004.
23. Frisch SM and Mymryk JS: Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 3: 441-452, 2002.
24. Flinterman M, Gäken J, Farzaneh F and Tavassoli M: E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines. Oncogene 22: 1965-1977, 2003.
25. Gugasyan R, Quilici C, Grail D et al: Dok-related protein negatively regulates T cell development via its RasGTPase-activating protein and Nek docking sites. J Cell Biol 158: 115-125, 2002.
26. Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM and Fry AM: The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res 64: 7370-7376, 2004.
27. Derynck R: TGF-beta-receptor-mediated signaling. Trends Biochem Sci 19: 548-553, 1994.
28. Hamdan M and Righetti PG: Modern strategies for protein quantification in proteome analysis: advantages and limitations. Mass Spectrom Rev 21: 287-302, 2002.
29. He QY, Chen J, Kung HF, Yuen AP and Chiu JF: Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4: 271-278, 2004.
30. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668, 2001.
31. Chen J, He QY, Yuen AP and Chiu JF: Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4: 2465-2475, 2004.
32. Hermeking H, Lengauer C, Polyak K, He TC et al: 14-3-3 Sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11, 1997.
33. Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T et al: Decreased expression of 14-3-3 sigma in neuroendocrine tumors is independent of origin and malignant potential. Oncogene 21: 8310-8319, 2002.
34. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H et al: Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 57: 4111-4117, 1997.
35. Lodygin D, Yazdi AS, Sander CA, Herzinger T et al: Analysis of 14-3-3 sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 22: 5519-5524, 2003.
36. Tsuchida S and Sato K: Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 27: 337-384, 1992.
37. Lafuente A, Maristany M, Arias C, Cuchi A et al: Glutathione and glutathione S-transferases in human squamous cell carcinomas of the larynx and GSTM1 dependent risk. Anticancer Res 18: 107-111, 1998.
38. Li TJ, Hirayama Y and Kitano M: Glutathione S-transferase pi-class as a tumour marker in lingual preneoplastic and neoplastic lesions of rats and humans. Virchows Arch 431: 37-43, 1997.
39. Zhang L, Xiao Y and Priddy R: Increase in placental glutathione S-transferase in human oral epithelial dysplastic lesions and squamous cell carcinomas. J Oral Pathol Med 23: 75-79, 1994.
40. Palackal NT, Lee SH, Harvey RG, Blair IA et al: Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J Biol Chem 277: 24799-24808, 2002.
41. Scuric Z, Stain SC, Anderson WF and Hwang JJ: New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology 27: 943-950, 1998.
42. Takahashi M, Fujii J, Miyoshi E, Hoshi A et al: Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes. Int J Cancer 62: 749-754, 1995.
43. Marshall K: Therapeutic applications of whey protein. Altern Med Rev 9: 136-156, 2004.
44. Costantini V and Zacharski LR: The role of fibrin in tumor metastasis. Cancer Metastasis Rev 11: 283-290, 1992.
45. Costantini V and Zacharski LR: Fibrin and cancer. Thromb Haemost 69: 406-414, 1993.
46. Maxim PE and Velti RW: Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck. Cancer 57: 305-311, 1986.
47. Ou K, Seow TK, Liang RC, Ong SE and Chung MC: Proteome analysis of a human heptocellular carcinoma cell line, HCC-M: an update. Electrophoresis 22: 2804-2811, 2001.